CD274 and neoplasm: Previous studies have reported that tumor PD-L1 interacts with its receptor PD1, suppresses the development of the T cell response and evades anti-tumor immunity.6,7 Moreover, increasing evidences demonstrate that both PD-L1 and PD1 also play intrinsic roles in cancer cell signaling.